Mariana Tedeschi Benatto1, Lidiane Lima Florencio1, Gabriela Ferreira Carvalho1, Fabíola Dach2, Marcelo Eduardo Bigal3, Thaís Cristina Chaves2, Débora Bevilaqua-Grossi1,4. 1. Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Biomecânica, Medicina e Reabilitação do Aparelho Locomotor, Programa de Pós-Graduação em Reabilitação em Desempenho Funcional, Ribeirão Preto SP, Brasil. 2. Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurociências e Ciências do Comportamento, Ribeirão Preto SP, Brasil. 3. Desenvolvimento Global da Teva Pharmaceutical Industries Ltd.,Filadélfia, EUA. 4. Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Laboratório de Análises da Postura e Movimento Humano (LAPOMH), Ribeirão Preto SP, Brasil.
Abstract
OBJECTIVE: To evaluate cutaneous allodynia among patients with chronic and episodic migraine in a tertiary headache clinic. METHODS: 80 subjects with episodic migraine and 80 with chronic migraine were assessed in a tertiary hospital. The 12-item Allodynia Symptom Checklist/Brazil questionnaire was applied to classify subjects according to the presence and severity of cutaneous allodynia. RESULTS: Cutaneous allodynia was identified in 81.3% of the episodic migraine group and 92.5% of the chronic migraine group (p = 0.03). No increased association could be attributed to chronic migraine when adjusted by years with disease (PR = 1.12; 95%CI = 0.99 to 1.27; p = 0.06). The groups also did not differ in the severity of allodynia, and severe presentation was the most frequent. DISCUSSION: Both groups seemed to be similarly affected in the cephalic and extracephalic regions, with the same severity. CONCLUSION: Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease.
OBJECTIVE: To evaluate cutaneous allodynia among patients with chronic and episodic migraine in a tertiary headache clinic. METHODS: 80 subjects with episodic migraine and 80 with chronic migraine were assessed in a tertiary hospital. The 12-item Allodynia Symptom Checklist/Brazil questionnaire was applied to classify subjects according to the presence and severity of cutaneous allodynia. RESULTS: Cutaneous allodynia was identified in 81.3% of the episodic migraine group and 92.5% of the chronic migraine group (p = 0.03). No increased association could be attributed to chronic migraine when adjusted by years with disease (PR = 1.12; 95%CI = 0.99 to 1.27; p = 0.06). The groups also did not differ in the severity of allodynia, and severe presentation was the most frequent. DISCUSSION: Both groups seemed to be similarly affected in the cephalic and extracephalic regions, with the same severity. CONCLUSION: Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease.
Authors: Mengya Wang; Thomas L Duong; Brandon J Rea; Jayme S Waite; Michael W Huebner; Harold C Flinn; Andrew F Russo; Levi P Sowers Journal: Front Pain Res (Lausanne) Date: 2022-04-25
Authors: Hassan Jassar; Thiago D Nascimento; Niko Kaciroti; Marcos F DosSantos; Theodora Danciu; Robert A Koeppe; Yolanda R Smith; Marcelo E Bigal; Frank Porreca; Kenneth L Casey; Jon-Kar Zubieta; Alexandre F DaSilva Journal: Neuroimage Clin Date: 2019-06-18 Impact factor: 4.881